AXGN:NASDAQ
AxoGen, Inc Common Stock
$55.75
arrow_downward
-1.06%(-0.60) 1D
$56.10
arrow_upward
+0.63% (+0.35)bedtimePagkalipas ng oras ng trabaho
Sarado: Nob 20, 4:00:02 PM GMT-5 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa AXGN...
Buksan
$55.71
Mataas
$56.91
Mababa
$55.03
Mkt. cap
3.33B
Avg. na dami
1.86M
Dami
876.07K
Mataas nang 52-wk
$59.72
Mababa nang 52-wk
$25.21
EPS
-$0.65
Beta
1.21
Mga natitirang share
59.73M
Bilang ng mga empleyado
622
Buksan
$55.71
Mataas
$56.91
Mababa
$55.03
Mkt. cap
3.33B
Avg. na dami
1.86M
Dami
876.07K
Mataas nang 52-wk
$59.72
Mababa nang 52-wk
$25.21
EPS
-$0.65
Beta
1.21
Mga natitirang share
59.73M
Bilang ng mga empleyado
622
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
ChartMill
·
9 oras ang nakalipas
Axogen (NASDAQ:AXGN) Clears the Minervini Trend Template, but Setup Quality Still Demands Patience
Profile
Axogen is a developer of surgical solutions, including human tissue grafts, based in Tampa, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology Avance to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator.
As of 2019, Axogen was the only commercially available nerve allograft approved by the Food and Drug Administration for clinical use. Wikipedia
Tungkol sa AxoGen, Inc Common Stock
CEO-
Mga Empleyado622
Itinatag2002
HeadquartersAlachua, Florida, Estados Unidos
SektorHealth Care
Industriya-
Websiteaxogeninc.com